These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1176767)

  • 21. Antibody-forming cells in the thymus of guinea pigs after intrathymic injection of sheep erythrocytes.
    Jokipii AM
    Ann Med Exp Biol Fenn; 1971; 49(4):176-9. PubMed ID: 4947392
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of the lytic effect of guinea pig complement by rabbit complement.
    Kempf RA; Gigli I; Austen KF
    J Immunol; 1969 Apr; 102(4):795-803. PubMed ID: 5768190
    [No Abstract]   [Full Text] [Related]  

  • 23. Differentiation of C3b receptors on human lymphocytes, phagocytes, erythrocytes and renal glomerulus cells by monoclonal antibodies.
    Dierich MP; Mussel HH; Scheiner O; Ehlen T; Burger R; Peters H; Schmitt M; Trepke S; Zimmer G
    Immunology; 1982 Jan; 45(1):85-96. PubMed ID: 7056569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rabbit antiserum to a thymus extract specific for mouse thymus-derived cells.
    Sarkar S; Hyman R; Masuda T; Herzenberg LA
    J Immunol; 1973 May; 110(5):1222-32. PubMed ID: 4633295
    [No Abstract]   [Full Text] [Related]  

  • 25. Autoagglutinin produced by organ fragment cultures of mouse spleen.
    Jablonska KF
    Eur J Immunol; 1977 Nov; 7(11):791-6. PubMed ID: 590321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-complementary substances produced by KB cell cultures infected and not infected with virus.
    Kósa Z; Füst G
    Acta Microbiol Acad Sci Hung; 1970; 17(4):381-91. PubMed ID: 4327674
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of human C 1 inhibitor on complement-mediated human leukocyte chemotaxis.
    Smith CW; Hollers JC; Bing DH; Patrick RA
    J Immunol; 1975 Jan; 114(1 Pt 1):216-20. PubMed ID: 1167560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response in vitro to Salmonella H-antigens, not affected by anti-theta serum.
    Diener E; O'Callaghan F; Kraft N
    J Immunol; 1971 Dec; 107(6):1775-7. PubMed ID: 4941116
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis of complement components (C3, C2, B and C1-inhibitor) and lysozyme by human monocytes and macrophages.
    Lappin D; Hamilton AD; Morrison L; Aref M; Whaley K
    J Clin Lab Immunol; 1986 Jul; 20(3):101-5. PubMed ID: 3638367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The alternate complement pathway in cell damage: antibody-mediated cytolysis of erythrocytes and nucleated cells.
    May JE; Green I; Frank MM
    J Immunol; 1972 Sep; 109(3):595-601. PubMed ID: 4115545
    [No Abstract]   [Full Text] [Related]  

  • 31. Sheep serum complement sensitisation of sheep erythrocyte-rabbit antibody complexes for haemolysis by guinea-pig complement plus EDTA or Mg2+-EGTA.
    Jonas W; Stankiewicz M
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):451-60. PubMed ID: 3099725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
    Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
    J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The third component of the guinea pig complement system. 3. Effect of inhibitors.
    Shin HS; Mayer MM
    Biochemistry; 1968 Aug; 7(8):3003-6. PubMed ID: 5666767
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of fibroblasts from monolayer cultures of hematopoietic and lymphoid tissue on the immune response in vitro].
    Sidorenko AV; Korukova AA; Grugor'eva OS; Gurvich AE
    Biull Eksp Biol Med; 1975 Dec; 80(12):62-5. PubMed ID: 1241517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relative toxicity of metal salts to immune hemolysis in a mixture of antibody-secreting spleen cells, sheep red blood cells and complement.
    Seko Y; Koyama T; Ichiki A; Sugamata M; Miura T
    Res Commun Chem Pathol Pharmacol; 1982 May; 36(2):205-13. PubMed ID: 6213005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A monoclonal antibody that blocks the complement regulatory activity of guinea pig erythrocytes and characterization of the antigen involved as guinea pig decay-accelerating factor.
    Okada N; Tanaka H; Takizawa H; Okada H
    J Immunol; 1995 Jun; 154(11):6103-11. PubMed ID: 7538542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. II. Physico-chemical characterization of the activated complex.
    Miyama A; Kato T; Yokoo J; Kashiba S
    Biken J; 1975 Dec; 18(4):205-14. PubMed ID: 1218075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor J: isolation and characterization of a new polypeptide inhibitor of complement C1.
    Lopez-Trascasa M; Bing DH; Rivard M; Nicholson-Weller A
    J Biol Chem; 1989 Sep; 264(27):16214-21. PubMed ID: 2476439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initiation of antibody production to sheep erythrocytes in vitro: replacement of the requirement for T-cells with a cell-free factor isolated from cultures of lymphoid cells.
    Gorczynski RM; Miller RG; Phillips RA
    J Immunol; 1972 Feb; 108(2):547-51. PubMed ID: 5065602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.